Honestly, the market feels like a fever dream sometimes. One minute you're staring at a sea of red, and the next, a handful of tickers start sprinting toward the moon for reasons that don't always make sense at first glance. If you’ve been watching the biggest gainers stocks today, specifically as we navigate this wild January 18, 2026, you know the vibe is erratic but profitable for those in the right seats.
The S&P 500 is currently playing a game of "will they, won't they" with its record highs, but the real action isn't in the broad indices. It's in the outliers. We are seeing massive rotations. Investors are getting bored with the same old mega-cap tech trade—though Microsoft (MSFT) is still doing its thing—and they're hunting for high-alpha plays in biotech and space tech.
The Biotech Breakout: ImmunityBio (IBRX) Stuns the Street
You've probably seen the ticker IBRX flashing on every scanner. ImmunityBio Inc. has been absolutely tearing it up, closing recently at $5.52, which is a massive 39.75% jump. That is not a typo.
Why the sudden surge? Well, biotech is a fickle beast, but when the volume hits 182 million shares against an average of 11 million, you know something big is happening. In this case, it’s the classic mix of clinical trial optimism and heavy institutional positioning. People are betting on their immunotherapy pipeline, and for a company that was trading near $1.83 within the last year, this is a life-changing move for some retail holders.
Kinda crazy, right? But that’s the nature of the biggest gainers stocks today. You have to be okay with the volatility. If you can't handle a 10% swing in an hour, biotech is basically a heart attack waiting to happen.
AST SpaceMobile (ASTS) and the New Space Race
Then there's AST SpaceMobile. If you haven't been following the "satellite-to-cell" story, you're missing out on one of the most polarizing trades of 2026. ASTS jumped 14.34% to reach $115.77.
- Market Cap: Cruising at $32.19 billion.
- The Narrative: They are building the first space-based cellular broadband network.
- The Momentum: Retail traders on Reddit and Twitter (X) are obsessed with this one.
It’s one of those stocks where the bears call it a "science project" and the bulls call it "the next Apple." Today, the bulls are clearly winning the argument. The volume was nearly triple the average, showing that big money is finally starting to treat space tech like a legitimate sector rather than a speculative fringe.
Bitcoin Proxy Plays: Riot Platforms (RIOT) Catches a Bid
You can't talk about market gainers without mentioning the crypto-adjacent stocks. Riot Platforms (RIOT) surged 16.11% to $19.24. This isn't just a random spike; it’s a direct reaction to Bitcoin’s price action and the ongoing "hashrate" wars.
When Riot moves this much, it’s usually because the "risk-on" appetite has returned to the market. Honestly, it’s a relief for those who bought the dip when it was sitting in the single digits. We’re also seeing similar moves in Iris Energy (IREN), which climbed over 11%. It seems the market is finally rewarding the miners that have the lowest power costs and the best balance sheets.
📖 Related: Customer Service Representative Duties: Why It’s More Than Just Answering Phones
What Most People Get Wrong About Daily Gainers
Most people see a stock up 20% and think, "I missed it." Sometimes that’s true. But often, these massive green days are just the start of a "breakaway gap."
Take Super Micro Computer (SMCI), for example. It gained nearly 11% today. This is a stock that has been through the ringer with accounting drama and delisting fears over the past couple of years. Now, it’s clawing its way back. A gain like this isn't just "noise"—it’s a signal that the sentiment is shifting from "fear" to "maybe this isn't going to zero."
How to Actually Trade the Biggest Gainers Stocks Today
Look, chasing a stock that is already up 40% is usually a recipe for disaster. You’ll end up being the "exit liquidity" for a hedge fund that’s been holding since the bottom. Instead, you need to look at the why behind the move.
- Check the Volume: If a stock is up 10% on low volume, ignore it. It’s a trap. If it’s up 10% on 5x its average volume, like we saw with ImmunityBio, that’s institutional interest.
- Look for the "Second Day" Play: Often, the biggest winners of today will see a slight pullback tomorrow morning. That "dip" is usually where the smart money enters for the next leg up.
- Mind the Relative Strength: Is the stock outperforming its sector? If RIOT is up 16% but the rest of the crypto sector is flat, Riot has a specific catalyst you need to research.
The biggest mistake is thinking these moves are random. They aren't. Whether it's a short squeeze or a genuine fundamental breakthrough, there is always a story. Your job isn't to find the story—it's to follow the price action.
Actionable Next Steps for Your Portfolio
If you are looking to capitalize on these moves, start by setting alerts for "Unusual Volume" on your brokerage platform. Don't just watch the percentage gainers; watch the stocks that are breaking out of a multi-month "base" on high volume.
💡 You might also like: Sam Nazarian Net Worth: What Most People Get Wrong
Tomorrow, keep a close eye on the $120 level for AST SpaceMobile. If it flips that resistance into support, we could see another massive run toward all-time highs. For the biotech plays like IBRX, keep your stop-losses tight. These things can give back 20% just as fast as they gained it. Stay nimble, keep your position sizes manageable, and stop trying to catch every single runner. One or two good trades a week is all you really need.